Panaxia Labs Israel Reports Q3 Record Revenues Of $7.15M, Up 34% YoY
Medical cannabis company Panaxia Labs Israel Ltd., a subsidiary of Panaxia Global (TASE: PNAX), reported its financial results on Monday for the third quarter revealing revenues of NIS22.5 million ($7.15 million), up by 34% from NIS16.8 million in the same period of last year.
